AdvaMed® submitted comments to the Centers for Medicaid and Medicaid Services (CMS) on the Fiscal Year 2023 Hospital Inpatient Prospective Payment System proposed rule. In this comment letter, AdvaMed® supported CMS’ proposal to implement a permanent 10% cap on year-over-year reductions to the Medicare Severity Diagnosis Related Groups (MS-DRGs), provided comment on a series of requests for information regarding the ongoing impact of the COVID-19 public health emergency, and reiterated previous recommendations for improvements to the New Technology Add-On Payment (NTAP) Program.
For more information on AdvaMed®’s efforts around hospital inpatient payment policy and the NTAP Program, please contact Richard Price and Kirsten Tullia.